Abstract 5399: QLS2309, a trifunctional NKp46/CD16a-NK cell engager targeting CD70 enhances efficacy against acute myeloid leukemia via mitigating the refraction to therapeutic antibody-dependent cytotoxicity.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Qilu Pharmaceutical Co., Ltd. (China)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148887641
Cites:
Cited by:
Related to: